MT-5562

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameMT-5562
Drug Alias NameMT-5562MT-5562FMT-5562-F
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors
TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2
Therapy Area/IndicationsScleroderma, SystemicPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma Corp
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A